Methylation kinetics and CpG-island methylator phenotyope status in colorectal cancer cell lines

Biology Direct

Volumn 8, Issue 1, 2013, Pages

  Wodarz, Dominik ^a   Boland, C Richard ^b   Goel, Ajay ^b   Komarova, Natalia L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

Mathematical modeling; Methylation kinetics; Methylation rates; Methylator phenotype

Indexed keywords

ANNA;

COLORECTAL TUMOR; CPG ISLAND; DNA METHYLATION; GENETICS; HUMAN; PHYSIOLOGY; THEORETICAL MODEL; TUMOR CELL LINE; ARTICLE;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; HUMANS; MODELS, THEORETICAL;

EID: 84878744149     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-8-14     Document Type: Article

References (51)

1. Vogelstein B. Kinzler KW (Eds.): The genetic basis of human cancers 2002, New York: McGraw-Hill.
2. Luebeck EG, Moolgavkar SH. Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA 2002, 99:15095-15100. 10.1073/pnas.222118199, 137549, 12415112.
3. Moolgavkar SH, Luebeck EG. Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer 2003, 38:302-306. 10.1002/gcc.10264, 14566848.
4. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823. 10.1073/pnas.68.4.820, 389051, 5279523.
5. Breivik J. The evolutionary origin of genetic instability in cancer development. Semin Cancer Biol 2005, 15:51-60. 10.1016/j.semcancer.2004.09.008, 15613288.
6. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392:300-303. 10.1038/32688, 9521327.
7. Chow M, Rubin H. Clonal selection versus genetic instability as the driving force in neoplastic transformation. Cancer Res 2000, 60:6510-6518.
8. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, Van Es JH, Breukel C, Wiegant J, Giles RH, Clevers H. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 2001, 3:433-438. 10.1038/35070129, 11283620.
9. Guo HH, Loeb LA. Tumbling down a different pathway to genetic instability. J Clin Invest 2003, 112:1793-1795. 297004, 14679175.
10. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997, 386:623-627. 10.1038/386623a0, 9121588.
11. Loeb KR, Loeb LA. Significance of multiple mutations in cancer. Carcinogenesis 2000, 21:379-385. 10.1093/carcin/21.3.379, 10688858.
12. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 2001, 61:818-822.
13. Tomlinson I. Different pathways of colorectal carcinogenesis and their clinical pictures. Ann N Y Acad Sci 2000, 910:10-18. discussion 18-20.
14. Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med 1999, 5:11-12. 10.1038/4687, 9883827.
15. Tomlinson IP, Novelli MR, Bodmer WF. The mutation rate and cancer. Proc Natl Acad Sci USA 1996, 93:14800-14803. 10.1073/pnas.93.25.14800, 26216, 8962135.
16. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol 1999, 9:M57-M60. 10.1016/S0962-8924(99)01661-X, 10611684.
17. Boland CR, Ricciardiello L. How many mutations does it take to make a tumor?. Proc Natl Acad Sci USA 1999, 96:14675-14677. 10.1073/pnas.96.26.14675, 33954, 10611270.
18. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland CR. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996, 56:1237-1240.
19. Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, et al. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 2003, 63:1608-1614.
20. Iacobuzio-Donahue CA. Epigenetic changes in cancer. Annu Rev Pathol 2009, 4:229-249. 10.1146/annurev.pathol.3.121806.151442, 18840073.
21. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428.
22. Laird PW, Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 1996, 30:441-464. 10.1146/annurev.genet.30.1.441, 8982461.
23. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36. 10.1093/carcin/bgp220, 2802667, 19752007.
24. Sugimura T, Ushijima T. Genetic and epigenetic alterations in carcinogenesis. Mutat Res 2000, 462:235-246. 10.1016/S1383-5742(00)00005-3, 10767635.
25. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004, 4:988-993. 10.1038/nrc1507, 15573120.
26. Nosho K, Irahara N, Shima K, Kure S, Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J, Spiegelman D, et al. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS One 2008, 3:e3698. 10.1371/journal.pone.0003698, 2579485, 19002263.
27. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999, 96:8681-8686. 10.1073/pnas.96.15.8681, 17576, 10411935.
28. Toyota M, Issa JP. CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 1999, 9:349-357. 10.1006/scbi.1999.0135, 10547343.
29. Ushijima T, Watanabe N, Shimizu K, Miyamoto K, Sugimura T, Kaneda A. Decreased fidelity in replicating CpG methylation patterns in cancer cells. Cancer Res 2005, 65:11-17.
30. Watanabe N, Okochi-Takada E, Yagi Y, Furuta JI, Ushijima T. Decreased fidelity in replicating DNA methylation patterns in cancer cells leads to dense methylation of a CpG island. Curr Top Microbiol Immunol 2006, 310:199-210. 10.1007/3-540-31181-5_10, 16909912.
31. Boland CR, Goel A. Somatic evolution of cancer cells. Semin Cancer Biol 2005, 15:436-450. 10.1016/j.semcancer.2005.06.001, 16055343.
32. Chen ZX, Mann JR, Hsieh CL, Riggs AD, Chedin F. Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem 2005, 95:902-917. 10.1002/jcb.20447, 15861382.
33. Denis H, Ndlovu MN, Fuks F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep 2011, 12:647-656. 10.1038/embor.2011.110, 3128952, 21660058.
34. McAdams HH, Arkin A. Stochastic mechanisms in gene expression. Proc Natl Acad Sci USA 1997, 94:814-819. 10.1073/pnas.94.3.814, 19596, 9023339.
35. Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004, 61:2571-2587. 10.1007/s00018-004-4201-1, 15526163.
36. Pradhan S, Bacolla A, Wells RD, Roberts RJ. Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation. J Biol Chem 1999, 274:33002-33010. 10.1074/jbc.274.46.33002, 10551868.
37. Jair KW, Bachman KE, Suzuki H, Ting AH, Rhee I, Yen RW, Baylin SB, Schuebel KE. De novo CpG island methylation in human cancer cells. Cancer Res 2006, 66:682-692. 10.1158/0008-5472.CAN-05-1980, 16423997.
38. Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer 2001, 91:205-212. 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2, 11146446.
39. Lee PJ, Washer LL, Law DJ, Boland CR, Horon IL, Feinberg AP. Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc Natl Acad Sci USA 1996, 93:10366-10370. 10.1073/pnas.93.19.10366, 38390, 8816806.
40. Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S. Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003, 105:527-532. 10.1002/ijc.11127, 12712445.
41. Turker MS. The establishment and maintenance of DNA methylation patterns in mouse somatic cells. Semin Cancer Biol 1999, 9:329-337. 10.1006/scbi.1999.0133, 10547341.
42. Slack A, Cervoni N, Pinard M, Szyf M. Feedback regulation of DNA methyltransferase gene expression by methylation. Eur J Biochem 1999, 264:191-199. 10.1046/j.1432-1327.1999.00603.x, 10447688.
43. Pfeuty B, Kaneko K. The combination of positive and negative feedback loops confers exquisite flexibility to biochemical switches. Phys Biol 2009, 6:046013. 10.1088/1478-3975/6/4/046013, 19910671.
44. Otto SP, Walbot V. DNA methylation in eukaryotes: kinetics of demethylation and de novo methylation during the life cycle. Genetics 1990, 124:429-437. 1203935, 2307364.
45. Sontag LB, Lorincz MC. Georg Luebeck E: Dynamics, stability and inheritance of somatic DNA methylation imprints. J Theor Biol 2006, 242:890-899. 10.1016/j.jtbi.2006.05.012, 16806276.
46. Genereux DP, Miner BE, Bergstrom CT, Laird CD. A population-epigenetic model to infer site-specific methylation rates from double-stranded DNA methylation patterns. Proc Natl Acad Sci USA 2005, 102:5802-5807. 10.1073/pnas.0502036102, 556300, 15827124.
47. Mossman D, Scott RJ. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation. PLoS One 2011, 6:e23127. 10.1371/journal.pone.0023127, 3150411, 21829702.
48. Esteller M. DNA methylation and cancer therapy: new developments and expectations. Curr Opin Oncol 2005, 17:55-60. 10.1097/01.cco.0000147383.04709.10, 15608514.
49. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, Goel A. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010, 70:6609-6618. 10.1158/0008-5472.CAN-10-0622, 2922409, 20682795.
50. Yang AS, Doshi KD, Choi SW, Mason JB, Mannari RK, Gharybian V, Luna R, Rashid A, Shen L, Estecio MR, et al. DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia. Cancer Res 2006, 66:5495-5503. 10.1158/0008-5472.CAN-05-2385, 16707479.
51. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004, 32:e38. 10.1093/nar/gnh032, 373427, 14973332.